Metcalfe, Kelly A.
,
Price, Melanie A.
Mansfield, Carol
Hallett, David C.
Lindeman, Geoffrey J.
Fairchild, Angie
Posner, Joshua
Friedman, Sue
Snyder, Carrie
Lynch, Henry T.
Evans, D. Gareth
Narod, Steven A.
Liede, Alexander
Article History
Received: 5 August 2019
Revised: 28 February 2020
Accepted: 6 April 2020
First Online: 12 May 2020
Ethics approval and consent to participate
: The following institutional review boards approved the study: RTI International Institutional Review Board, Research Triangle Park, USA; Social Behavioral Institutional Review Board, Creighton University, Omaha, USA; Research Office, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; The Peter MacCallum Cancer Centre Ethics Committee, Melbourne, Australia; Women’s College Hospital Research Ethics Board, Toronto, Canada. All participants provided informed consent prior to their inclusion in the study. This study was performed in accordance with the Declaration of Helsinki.
: None.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: D.C.H. discloses salary compensation and stock ownership with Amgen Inc. (Thousand Oaks, CA). A.L. discloses salary and stock ownership with Amgen Inc. during the time of study conduct; salary and stock ownership with AbbVie Inc. (North Chicago, IL) as of April 2019. C.M. is a current and J.P. is a former employee of RTI Health Solutions that were contracted by Amgen Inc. for the conduct of this study. S.A.N. is an Editorial Board Member of the British Journal of Cancer. No other conflicts of interest are declared for remaining authors.
: RTI Health Solutions received funding from Amgen Inc. (Thousand Oaks, CA, USA) for this study (study no. 20140153). This publication was also supported by revenue from Nebraska’s excise tax on cigarettes awarded to Creighton University through the Nebraska Department of Health & Human Services (DHHS). Its contents represent the views of the authors and do not necessarily represent the official views of the State of Nebraska or DHHS. Funding was also received from the Liz’s Legacy fund through Kicks for a Cure. Dr. H.T.L.’s work was partially funded through the Charles F. and Mary C. Heider Chair in Cancer Research, which he held at Creighton University. D.G.E. is supported by the all Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007).